A Study of SSGJ-613 in Gout Participants Initiating Urate-Lowering Treatment
Conditions : Gout Arthritis Interventions : Drug: SSGJ-613 100 mg Q12W; Drug: SSGJ-613 200 mg Q12W; Drug: SSGJ-613 100 mg Q4W; Drug: Colchicine 0.5 mg Sponsors : Sunshine Guojian Pharmaceutical…
Read the full article2d agoen
Comments
Sign in to join the conversation.
No comments yet. Be the first.